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Tables S4-S10 summarize the 25
o
C titration data (titrant volumes and pHfinal) of desipramine hydrochloride (or free 
base) in a procedure guided by pDISOL-X simulations (pH-Ramp Shake-Flask method) and consensus 
recommendations of a recent “white paper” on solubility methodology (Avdeef et al. 2016). The final pH 
measurements were obtained after equilibration (6 h stir, followed by 18 h sedimentation without stirring). All drug 
concentrations were measured by HPLC-UV/VIS.
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Table S1. Initial composition of stock suspensions  











 0.41170 11.62 0.03 0.12 0.03 
2 50.0
b
 0.41220 11.61 0.03 0.12 0.03 
3 15.0
b
 0.34370 1.90 0.08 0.14 0.14 
4 0.900
c
 0.08650-0.08730 4.34 0.32 0.15 0.32 
5 1.000
d
 0.04745-0.11205 1.31-10.04 0.15-0.37 – 0.15-0.40 
a
Weight of DsHCl added to the initial volumes indicated. 
b
Initial volume of stock suspension which was further apportioned into 1 or 2 mL aliquots and pH-adjusted with HCl/NaOH (cf., Tables S4-S6).  
c
Initial volume of 0.15 M NaH2PO4, the pH of which was adjusted with H3PO4, or HCl, or NaOH (cf., Table S7). 
d
Initial volume of 0.15 M NaCl, the pH of which was adjusted with HCl or NaOH (cf., Table S8). 
e
Total quantity of DsHCl/NaH2PO4/Cl per 1 L of initial prepared suspension. 
 
Table S2. Series 1 – concentrated suspension to collect compound for solid state characterisationa 
Sample 
42PONaH
V  (ml) mDsHCl (g)
b







OM11 2.000 0.17615 3.92 100 – 2.09 0.28 0.14 0.33 
OM12 2.000 0.16315 3.90 – 20 3.86 0.27 0.15 0.27 
OM13 2.000 0.15035 3.78 – 270 7.41 0.22 0.13 0.22 
OM14 2.000 0.13580 3.80 – 300 9.57 0.19 0.13 0.19 
OM15 2.000 0.13950 3.84 – 600 11.10 0.18 0.12 0.18 
a
2-mL solutions of 0.15 M NaH2PO4 with pH adjusted by HCl/NaOH: titrants cHCl=1.0211 M and cNaOH=1.1047 M. See text. 
b
Weight of DsHCl added to 2-mL volumes of 0.15 M NaH2PO4. 
c
Total quantity of DsHCl/NaH2PO4/Cl per 1 L of final suspension. 
 




































 – – 0.09605 – 5.99 400 – 2.13 0.28 0.31 – 
OM22 2.00
b
 – – – 0.14995 3.87 – – 3.84 0.25 0.15 0.25 
OM23 – 0.07000 3.000 – 0.24980 3.95 – 410 8.03 0.24 0.13 0.24 
OM24 – 0.06995 3.000 – 0.24985 3.96 – 450 9.44 0.24 0.13 0.24 




Initial volumes of 0.15 M NaH2PO4, with pH adjusted by H3PO4/NaOH: titrants 
43POH
c =1.0048 M and cNaOH =1.1047 M. See text. 
c
Total quantity of DsHCl/NaH2PO4/Cl per 1 L of final suspension. 
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Table S4. Set 1 – desipramine hydrochloride high-to-low pH titration and solubility dataa 
Sample  pHinit VHCl (µL) VNaOH (µL) pHfinal S (M) log S 
1  11.27 410 – 4.42 1.48×10
-2
 -1.83 
2  11.52 350 – 6.00 2.59×10
-3
 -2.59 
3  11.60 320 – 6.51 1.86×10
-3
 -2.73 
4  11.55 205 – 7.39 1.29×10
-3
 -2.89 
5  11.48 194 5 7.97 1.27×10
-3
 -2.90 
6  11.33 210 40 8.55 1.22×10
-3
 -2.91 
7  11.49 180 5 8.72 1.27×10
-3
 -2.90 
8  11.56 143 – 9.46 1.25×10
-3
 -2.90 
9  11.50 130 10 9.81 1.11×10
-3
 -2.95 
10  11.52 130 – 10.10 6.74×10
-4
 -3.17 
11  11.50 100 – 10.62 3.06×10
-4
 -3.51 
12  11.60 50 – 11.26 1.98×10
-4
 -3.70 




Initial suspension volume 2 mL. Phases separated by filtration. No solid detected below pH 4. 
Titrants added in increments during mixing as pH was changing: cHCl =0.9896 M, cNaOH =1.0074 M 
 
 











Sample  pHinit VHCl (µL) VNaOH (µL) pHfinal S (M) log S 
1  11.51 400 – 4.78 9.71×10
-3
 -2.01 
2  11.58 401 20 5.36 5.29×10
-3
 -2.28 
3  11.60 360 – 6.03 2.79×10
-3
 -2.55 
4  11.59 300 – 6.58 1.87×10
-3
 -2.73 
5  11.56 200 – 7.50 1.34×10
-3
 -2.87 
6  11.45 170 – 7.78 1.15×10
-3
 -2.94 
7  11.62 180 20 8.12 1.13×10
-3
 -2.95 
8  11.54 163 20 8.47 1.14×10
-3
 -2.94 
9  11.48 130 – 9.71 1.22×10
-3
 -2.91 
10  11.61 125 – 10.06 5.81×10
-3
 -3.24 
11  11.51 100 – 10.56 2.62×10
-3
 -3.58 
12  11.57 50 – 11.02 1.80×10
-3
 -3.74 




See footnotes in Table S4. 
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Table S6. Set 3 – desipramine hydrochloride low-to-high pH titration and solubility dataa 
Sample  pHinit VNaOH (µL) VHCl (µL) pHfinal S (M) log S 
1  1.86 80 – 3.99 4.51×10
-2
 -1.35 
2  1.87 100 – 4.73 1.13×10
-2
 -1.95 
3  1.89 150 50 5.19 9.24×10
-3
 -2.03 
4  1.88 120 – 6.04 3.30×10
-3
 -2.48 
5  1.88 150 – 6.69 2.23×10
-3
 -2.65 
6  1.92 180 – 7.14 1.78×10
-3
 -2.75 
7  1.94 200 – 7.79 1.70×10
-3
 -2.77 
8  1.91 220 – 9.64 1.69×10
-3
 -2.77 
9  1.91 280 – 10.08 4.68×10
-4
 -3.33 
10  1.89 325 – 11.00 1.55×10
-4
 -3.81 




Initial solution volumes were 1 mL in all cases. Phases separated by centrifugation. Otherwise, see 
footnote in Table S4. 
 
 
Table S7. Set 4 – concentrated desipramine hydrochloride solubility dataa 
Sample 
42PONaH
V (mL) mDsHCl (g) VNaOH (µL) 43POHV (µL) VHCl (µL) pHfinal S (M)
d
 log S 
1 0.90 0.08660 – 40 – 2.42 0.281 -0.55 
2 0.90 0.08650 10 13 – 3.59 0.288 -0.54 
3 0.90 0.08730 – – 50 2.02 0.245 -0.61 
a
Stock [NaH2PO4] = 0.15 M, pH 4.34. Titrant concentrations: cHCl = 1.0032 M, cNaOH = 1.0215 M,  
43POH
c   = 1.0048 M. Phases separated by centrifugation for Samples 1 and 2, and by filtration for Sample 3. 
 
 
Table S8. Set 5 – phosphate-free desipramine hydrochloride titration and solubility dataa 
Sample mDsHCl (g) VNaOH (µL) VHCl (µL) pHfinal S (M) log S 
1 0.10955 53 100 1.31 2.78×10
-2
 -1.56 
2 0.11205 – 4 2.38 3.00×10
-2
 -1.52 
3 0.09140 23 25 3.02 3.88×10
-2
 -1.41 
4 0.05300 – – 4.93 4.32×10
-2
 -1.36 
5 0.04745 5 – 7.59 8.24×10
-2
 -1.08 
6 0.05475 130 – 8.98 3.79×10
-3
 -2.42 




Initially, each sample vial contained 1 mL 0.15 M NaCl. Titrant concentrations: cHCl 1.0211 M, 




Table S9. Series 1 – solubility-pH results 
Sample pHfinal S (M) log S 
OM11 2.09 0.200 -0.70 











Table S10. Series 2 – solubility-pH results 






















Figure S1. Equilibration of samples OM23 (pH 8.03) and OM13 (pH 7.41) at 25°C and 50% RH:  
(a) Moisture desorption by OM23 during equilibration at 25°C/50% RH,  
(b) TGA scan of OM23 after equilibration showing the total moisture content,  
(c) moisture sorption by OM13 during equilibration at 25°C/50% RH, and  






 a)  b) 




 g)  h) 
 i)  j) 
 k) 
 
Figure S2. HPLC Chromatograms for Set 3 samples at different pH values:  
a) Sample 1 – pH 3.99, diluted 100; b) Sample 2 – pH 4.73, diluted 60;  
c) Sample 3 – pH 5.19, diluted 40; d) Sample 4 – pH 6.04, diluted 20; 
e) Sample 5 – pH 6.69, diluted 10;  f) Sample 6 – pH 7.14, diluted 4; 
g) Sample 7 – pH 7.79, diluted 10;  h) Sample 8 – pH 9.64, diluted 10; 
i) Sample 9 – pH 10.08, diluted 2;  j) Sample 10 – pH 11.00, diluted 2; 




Figure S3. Calibration diagram for desipramine (concentration range 1.00×10
-5– 5.00×10-4 M) Linear fit: 
Peak area=8.7829×10
-6
c + 4.4574 
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